K Roztocĭl

906 total citations
32 papers, 304 citations indexed

About

K Roztocĭl is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Internal Medicine. According to data from OpenAlex, K Roztocĭl has authored 32 papers receiving a total of 304 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Surgery, 11 papers in Cardiology and Cardiovascular Medicine and 9 papers in Internal Medicine. Recurrent topics in K Roztocĭl's work include Peripheral Artery Disease Management (13 papers), Diagnosis and Treatment of Venous Diseases (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). K Roztocĭl is often cited by papers focused on Peripheral Artery Disease Management (13 papers), Diagnosis and Treatment of Venous Diseases (9 papers) and Venous Thromboembolism Diagnosis and Management (9 papers). K Roztocĭl collaborates with scholars based in Czechia, United States and Germany. K Roztocĭl's co-authors include I Oliva, I Přerovský, Eberhard Rabe, Giovanni B. Agus, Viera Štvrtinová, Idaira Oliva, Jonathan Ipser, Aline G. Fischer, Věra Lánská and Michal Dubský and has published in prestigious journals such as Atherosclerosis, JAMA Network Open and Frontiers in Endocrinology.

In The Last Decade

K Roztocĭl

31 papers receiving 283 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Roztocĭl Czechia 11 221 118 56 32 30 32 304
K. Katsenis Greece 12 218 1.0× 66 0.6× 47 0.8× 21 0.7× 16 0.5× 36 426
Kirienko Ai Russia 13 374 1.7× 238 2.0× 27 0.5× 28 0.9× 22 0.7× 55 468
Mo Al-Qaisi United Kingdom 6 147 0.7× 30 0.3× 79 1.4× 83 2.6× 9 0.3× 6 270
Yahui Fu China 11 185 0.8× 81 0.7× 61 1.1× 22 0.7× 5 0.2× 23 409
Rosalía Pérez Spain 5 149 0.7× 36 0.3× 47 0.8× 10 0.3× 10 0.3× 7 314
D Houlbert France 5 165 0.7× 147 1.2× 130 2.3× 150 4.7× 10 0.3× 11 356
M. Pfisterer Switzerland 6 223 1.0× 136 1.2× 340 6.1× 11 0.3× 19 0.6× 9 453
Alessandro Aliotta Switzerland 11 59 0.3× 45 0.4× 47 0.8× 7 0.2× 33 1.1× 27 327
S. Klein United States 8 115 0.5× 118 1.0× 52 0.9× 33 1.0× 4 0.1× 12 284
Rodrigo Gibin Jaldin Brazil 8 117 0.5× 37 0.3× 50 0.9× 15 0.5× 31 1.0× 35 261

Countries citing papers authored by K Roztocĭl

Since Specialization
Citations

This map shows the geographic impact of K Roztocĭl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Roztocĭl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Roztocĭl more than expected).

Fields of papers citing papers by K Roztocĭl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Roztocĭl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Roztocĭl. The network helps show where K Roztocĭl may publish in the future.

Co-authorship network of co-authors of K Roztocĭl

This figure shows the co-authorship network connecting the top 25 collaborators of K Roztocĭl. A scholar is included among the top collaborators of K Roztocĭl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Roztocĭl. K Roztocĭl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Roztocĭl, K, et al.. (2023). Chronic Venous Disease and Its Intersections With Diabetes Mellitus. Physiological Research. 72(3). 280–286. 8 indexed citations
2.
Fejfarová, Vladimı́ra, Jiří Matuška, Edward B. Jude, et al.. (2021). Stimulation TcPO2 Testing Improves Diagnosis of Peripheral Arterial Disease in Patients With Diabetic Foot. Frontiers in Endocrinology. 12. 744195–744195. 20 indexed citations
3.
Šedivý, Petr, Monika Dezortová, Vı́t Herynek, et al.. (2018). 31P-MR spectroscopy in patients with mild and serious lower limb ischemia. International Angiology. 37(4). 293–299. 10 indexed citations
4.
Rabe, Eberhard, Giovanni B. Agus, & K Roztocĭl. (2015). Analysis of the effects of micronized purified flavonoid fraction versus placebo on symptoms and quality of life in patients suffering from chronic venous disease: from a prospective randomized trial.. PubMed. 34(5). 428–36. 39 indexed citations
5.
Antignani, Pier Luigi, Iris Baumgärtner, Francine Blei, et al.. (2015). ISVI-IUA consensus document diagnostic guidelines of vascular anomalies: vascular malformations and hemangiomas.. PubMed. 34(4). 333–74. 23 indexed citations
6.
Roztocĭl, K. (2014). Co nového je ve farmakoterapii žilních onemocnění. Interní medicína pro praxi. 16(1). 5–10.
7.
Kalodiki, Evi, Romeo Martini, E Minar, et al.. (2014). Consensus Document on Intermittent Claudication from the Central European Vascular Forum (C.E.V.F.)-3rd revision (2013) with the sharing of the Mediterranean League of Angiology and Vascular Surgery, and the North Africa and Middle East Chapter of International Union of Angiology.. PubMed. 33(4). 329–47. 3 indexed citations
8.
Karetová, Debora, et al.. (2012). The Czech ABI Project - prevalence of peripheral arterial disease in patients at risk using the ankle-brachial index in general practice (a cross-sectional study).. PubMed. 33 Suppl 2. 32–7. 1 indexed citations
9.
Lánská, Věra, et al.. (2011). Association between symptoms of chronic venous disease in the lower extremities and cardiovascular risk factors in middle-aged women.. PubMed. 30(4). 335–41. 11 indexed citations
10.
Michálek, Pavel, et al.. (2007). Radiofrequency thoracic sympathetic denervation a new option in the treatment of ischemic upper limb conditions. Cor et Vasa. 49(1). 13–18. 2 indexed citations
11.
Roztocĭl, K, et al.. (1989). The effect of hydroxyethylrutoside and its combination with acetylsalicylic acid in patients with obliterative atherosclerosis.. PubMed. 31(2). 128–33. 2 indexed citations
12.
Roztocĭl, K, I Přerovský, & I Oliva. (1986). Capillary filtration coefficient in the forearm of patients with essential hypertension. Clinical Physiology. 6(1). 77–83. 3 indexed citations
13.
Roztocĭl, K, I Přerovský, & I Oliva. (1979). The effect of intermittent compression on blood and lymph flow rates in the lower limbs.. PubMed. 8(4). 346–8. 3 indexed citations
14.
Roztocĭl, K, et al.. (1978). Hemodynamic effects of intravenous furosemide on peripheral circulation in humans.. PubMed. 7(1). 86–9. 5 indexed citations
15.
Roztocĭl, K, I Přerovský, & Idaira Oliva. (1977). The effect of hydroxyethylrutosides on capillary filtration rate in the lower limb of man. European Journal of Clinical Pharmacology. 11(6). 435–438. 26 indexed citations
16.
Roztocĭl, K, et al.. (1976). Capillary diffusion capacity for I-131 in the subcutaneous tissue of the lower extremities in patients with diabetes mellitus.. PubMed. 5(4). 338–41. 3 indexed citations
17.
Hladovec, J, I Přerovský, & K Roztocĭl. (1973). The Influence of Inflammation on the <sup>125</sup>I-Fibrinogen Uptake Test in Experimental Thrombosis. Journal of Vascular Research. 10(2). 93–100. 1 indexed citations
18.
Přerovský, I, et al.. (1972). The Effect of Hydroxyethylrutosides after Acute and Chronic Oral Administration in Patients with Venous Diseases. Journal of Vascular Research. 9(3-6). 408–414. 16 indexed citations
19.
Roztocĭl, K, et al.. (1971). The effect of 0-(β-hydroxyethyl)-rutosides (HR) on the peripheral circulation in patients with chronic venous insufficiency. European Journal of Clinical Pharmacology. 3(4). 243–246. 12 indexed citations
20.
Roztocĭl, K, et al.. (1971). The effect of 0-(β-hydroxyl)-rutosides (HR) on peripheral blood vessels of the lower extremities in idiopathic oedema. European Journal of Clinical Pharmacology. 3(4). 247–251. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026